Gut bugs may hold key to menopause nutrition

NCT ID NCT07182370

Ongoing Knowledge-focused Sponsor: National Research Council, Spain Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at how the gut microbiome influences the way menopausal women process plant compounds like resveratrol and isoflavones. Researchers will give 90 women either plant extract capsules or a placebo for eight weeks, then measure changes in heart health markers and quality of life. The goal is to understand why women respond differently to these nutrients, paving the way for personalized diet advice during menopause.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: plant extracts (resveratrol, ellagic acid, isoflavones)
What this could lead to: If successful, this could lead to personalized nutrition plans for menopausal women to improve well-being and reduce heart disease risk.
What could go wrong: This is a small, early-stage study (90 participants) focused on understanding biological markers, not proving a treatment works. Results may not apply to all women.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR RISK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Endotoxemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOVASCULAR RISK MENOPAUSE RELATED CONDITIONS

Contacts and locations

Show contact details

Locations

Centro de Edafología y Biología Aplicada del Segura (CEBAS-CSIC)

Murcia, Murcia, 30100, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.